Van Eck Associates Corp Shockwave Medical, Inc. Transaction History

Van Eck Associates Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	SELL	$191.17 - $325.63 $18,161 - $30,934	-95 Reduced 3.03%	3,040 $989,000
Q4 2023 Feb 05, 2024	SELL	$160.99 - $215.69 $85,646 - $114,747	-532 Reduced 14.51%	3,135 $597,000
Q3 2023 Nov 08, 2023	SELL	$194.33 - $283.97 $211,042 - $308,391	-1,086 Reduced 22.85%	3,667 $730,000
Q2 2023 Aug 03, 2023	SELL	$223.05 - $302.68 $1.13 Million - $1.53 Million	-5,069 Reduced 51.61%	4,753 $1.36 Million
Q1 2023 May 03, 2023	BUY	$175.41 - $217.92 $939,671 - $1.17 Million	5,357 Added 119.98%	9,822 $2.13 Million
Q4 2022 Feb 08, 2023	BUY	$204.38 - $296.82 $224,818 - $326,502	1,100 Added 32.69%	4,465 $918,000
Q3 2022 Oct 27, 2022	BUY	$195.21 - $310.53 $656,881 - $1.04 Million	3,365 New	3,365 $936,000

321K

1.9K

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

Stay updated on Van Eck Associates Corp with notifications on news.